Therapeutics Acquisition Corp. (RACA)
Therapeutics Acquisition Corp. operates in the Shell Companies industry of the Financial Services sector, headquartered in Boston, MA, US. The stock last traded at $10.27, up 2.44% on the session, giving a market capitalisation of $1.09B. On trailing twelve-month figures it carries a trailing P/E of 0.00, a net margin of 0.0%. Its beta of 0.00 implies it has historically moved less than the broad market.
Therapeutics Acquisition Corp., which operates as Research Alliance Corp. I, was founded in 2020 and is headquartered in Boston, Massachusetts. Its core mission is to pursue a business combination, including but not limited to mergers, capital stock exchanges, asset acquisitions, share purchases, or reorganizations, with one or more enterprises in the United States healthcare sector.
Therapeutics Acquisition Corp. is most often compared with the following Financial Services names: